The role of inflammation in the pathology of preeclampsia

Clinical Science

Volumn 130, Issue 6, 2016, Pages 409-419

  Harmon, Ashlyn C ^a   Cornelius, Denise C ^a   Amaral, Lorena M ^a   Faulkner, Jessica L ^a   Cunningham, Mark W ^a   Wallace, Kedra ^a   LaMarca, Babbette ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

Hypertension; Inflammation; Pregnancy

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; AUTOANTIBODY; ENDOGLIN; ENDOTHELIN 1; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 4; INTERLEUKIN 6; PREPROENDOTHELIN 1; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN RECEPTOR 1;

ADOPTIVE TRANSFER; ANTIBODY PRODUCTION; AORTA CONSTRICTION; AUTOIMMUNE DISEASE; BLOOD PRESSURE; CD4+ T LYMPHOCYTE; CHRONIC INFLAMMATION; CYTOKINE PRODUCTION; ELEVATED BLOOD PRESSURE; ENDOTHELIAL DYSFUNCTION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOLOGY; INFLAMMATION; INTRAUTERINE GROWTH RETARDATION; ISCHEMIA; MEAN ARTERIAL PRESSURE; MEDIATOR RELEASE; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PERIPHERAL CIRCULATION; PLACENTA CIRCULATION; PLACENTA ISCHEMIA; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; SMALL FOR DATE INFANT; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TH17 CELL; UTERUS BLOOD FLOW; ANIMAL; DISEASE MODEL; FEMALE; IMMUNOLOGY; PHYSIOLOGY;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; INTERLEUKIN-10; PLACENTAL CIRCULATION; PRE-ECLAMPSIA; PREGNANCY;

EID: 84958074198     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20150702     Document Type: Review

References (153)

1. Herse, F. and LaMarca, B. (2013) Angiotensin II type 1 receptor autoantibody (AT1-AA)-mediated pregnancy hypertension. Am. J. Reprod. Immunol. 69, 413-438
2. NHBPEP (2000) Report of the national high blood pressure education program working group on high blood pressure in pregnancy. Am. J. Obstet. Gynecol. +183, S1-S22
3. Noris, M., Perico, N. and Remuzzi, G. (2005) Mechanisms of disease: pre-eclampsia. Nat. Clin. Pract. Nephrol. 1, 98-114
4. Keyes, L.E., Armaza, J.F., Niermeyer, S., Vargas, E., Young, D.A. and Moore, L.G. (2003) Intrauterine growth restriction, preeclampsia, and intrauterine mortality at high altitude in Bolivia. Pediatr. Res. 54, 20-25
5. Lachmeijer, A.M., Arngrimsson, R., Bastiaans, E.J., Frigge, M.L., Pals, G., Sigurdardottir, S., Stéfansson, H., Pálsson, B., Nicolae, D., Kong, A. et al. (2001) A genome-wide scan for preeclampsia in the Netherlands. Eur. J. Hum. Genet. 9, 758-764
6. Ghiringhelli, F., Menard, C., Martin, F. and Zitvogel, L. (2006) The role of regulatory T cells in the control of natural killer cells: relevance during tumor progression. Immunol. Rev. 214, 229-238
7. Witlin, A.G. and Sibai, B.M. (1998) Magnesium sulfate therapy in preeclampsia and eclampsia. Obstet. Gynecol. 92, 883-889
8. Sibai, B.M. (2003) Diagnosis and management of gestational hypertension and preeclampsia. Obstet. Gynecol. 102, 181-192
9. Sibai, B.M. (2002) Chronic hypertension in pregnancy. Obstet. Gynecol. +100, 369-377
10. Granger, J.P., Alexander, B.T., Llinas, M.T., Bennett, W.A. and Khalil, R.A. (2001) Pathophysiology of hypertension during preeclampsia linking placental ischemia with endothelial dysfunction. Hypertension 38 3 Pt 2, 718-722
11. Roberts, J.M. and Gammill, H.S. (2005) Preeclampsia: recent insights. Hypertension 46, 1243-1249
12. Roberts, D.J. and Post, M.D. (2008) pre-eclampsia and intrauterine growth restriction. J. Clin. Pathol. 61, 1254-1260
13. Roberts, J.M. and Escudero, C. (2012) The placenta in preeclampsia. Pregnancy Hypertens 2, 72-83
14. Lala, P.K. and Chakraborty, C. (2003) Factors regulating trophoblast migration and invasiveness: possible derangements contributing to pre-eclampsia and fetal injury. Placenta +24, 575-587
15. Wells, M. (2007) The pathology of gestational trophoblastic disease: recent advances. Pathology 39, 88-96
16. King, A. (2000) Uterine leukocytes and decidualization. Hum. Reprod. Update 6, 28-36
17. Trundley, A. and Moffett, A. (2004) Human uterine leukocytes and pregnancy. Tissue Antigens 63, 1-12
18. Williams, P.J., Searle, R.F., Robson, S.C., Innes, B.A. and Bulmer, J.N. (2009) Decidual leucocyte populations in early to late gestation normal human pregnancy. J. Reprod. Immunol. 82, 24-31
19. Herberts, C., Melgert, B., van der Laan, J.W. and Faas, M. (2010) New adjuvanted vaccines in pregnancy: what is known about their safety? Expert Rev. Vaccines 9, 1411-1422
20. Lash, G.E., Robson, S.C. and Bulmer, J.N. (2010) Review: functional role of uterine natural killer (uNK) cells in human early pregnancy decidua. Placenta +31 Suppl, S87-S92
21. Nagamatsu, T. and Schust, D.J. (2010) The immunomodulatory roles of macrophages at the maternal-fetal interface. Reprod. Sci. 17, 209-218
22. Silva, L.M., Coolman, M., Steegers, E.A., Jaddoe, V.W., Moll, H.A., Hofman, A., Mackenbach, J.P. and Raat, H. (2008) Low socioeconomic status is a risk factor for preeclampsia: the generation R study. J. Hypertension 26, 1200-1208
23. Craven, C.M., Morgan, T. and Ward, K. (1998) Decidual spiral artery remodelling begins before cellular interaction with cytotrophoblasts. Placenta +19, 241-252
24. Hanna, J., Goldman-Wohl, D., Hamani, Y., Avraham, I., Greenfield, C., Natanson-Yaron, S., Prus, D., Cohen-Daniel, L., Arnon, T.I., Manaster, I. et al. (2006) Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat. Med. 12, 1065-1074
25. Somerset, D.A., Zheng, Y., Kilby, M.D., Sansom, D.M. and Drayson, M.T. (2004) Normal human pregnancy is associated with an elevation in the immune suppressive CD25 CD4+ regulatory T-cell subset. Immunology 112, 38-43
26. Tilburgs, T., Roelen, D.L., van der Mast, B.J., de Groot-Swings, G.M., Kleijburg, C., Scherjon, S.A. and Claas, F.H. (2008) Evidence for a selective migration of fetus-specific CD4+CD25 bright regulatory T cells from the peripheral blood to the decidua in human pregnancy. J. Immunol. 180, 5737-5745
27. Miyazaki, S., Tsuda, H., Sakai, M., Hori, S., Sasaki, Y., Futatani, T., Miyawaki, T. and Saito, S. (2003) Predominance of Th2-promoting dendritic cells in early human pregnancy decidua. J. Leukoc. Biol. 74, 514-522
28. Redman, C.W. and Sargent, I.L. (2010) Immunology of pre-eclampsia. Am. J. Reprod. Immunol. 63, 534-543
29. Veenstra van Nieuwenhoven, A.L., Heineman, M.J. and Faas, M.M. (2003) The immunology of successful pregnancy. Hum. Reprod. Update 9, 347-357
30. Davis, D., Kaufmann, R. and Moticka, E.J. (1998) Nonspecific immunity in pregnancy: monocyte surface Fcgamma receptor expression and function. J. Reprod. Immunol. 40, 119-128
31. Luppi, P., Haluszczak, C., Betters, D., Richard, C.A., Trucco, M. and DeLoia, J.A. (2002) Monocytes are progressively activated in the circulation of pregnant women. J. Leukoc. Biol. 72, 874-88432
32. Naccasha, N., Gervasi, M.T., Chaiworapongsa, T., Berman, S., Yoon, B.H., Maymon, E. and Romero, R. (2001) Phenotypic and metabolic characteristics of monocytes and granulocytes in normal pregnancy and maternal infection. Am. J. Obstet. Gynecol. +185, 1118-1123
33. Shin, S., Jang, J.Y., Roh, E.Y., Yoon, J.H., Kim, J.S., Han, K.S., Kim, S., Yun, Y., Choi, Y.S., Choi, J.D. et al. (2009) Differences in circulating dendritic cell subtypes in pregnant women, cord blood and healthy adult women. J. Korean Med. Sci. 24, 853-859
34. Ueda, Y., Hagihara, M., Okamoto, A., Higuchi, A., Tanabe, A., Hirabayashi, K., Izumi, S., Makino, T., Kato, S. and Hotta, T. (2003) Frequencies of dendritic cells (myeloid DC and plasmacytoid DC) and their ratio reduced in pregnant women: comparison with umbilical cord blood and normal healthy adults. Hum. Immunol. 64, 1144-1151
35. Miwa, N., Hayakawa, S., Miyazaki, S., Myojo, S., Sasaki, Y., Sakai, M., Takikawa, O. and Saito, S. (2005) IDO expression on decidual and peripheral blood dendritic cells and monocytes/macrophages after treatment with CTLA-4 or interferon-gamma increase in normal pregnancy but decrease in spontaneous abortion. Mol. Hum. Reprod. 11, 865-870
36. von Rango, U., Krusche, C.A., Beier, H.M. and Classen-Linke, I. (2007) Indoleamine-dioxygenase is expressed in human decidua at the time maternal tolerance is established. J. Reprod. Immunol. 74, 34-45
37. Freeman, D.J., McManus, F., Brown, E.A., Cherry, L., Norrie, J., Ramsay, J.E., Clark, P., Walker, I.D., Sattar, N. and Greer, I.A. (2004) Short- and long-term changes in plasma inflammatory markers associated with preeclampsia. Hypertension 44, 708-714
38. LaMarca, B., Cornelius, D. and Wallace, K. (2013) Elucidating immune mechanisms causing hypertension during pregnancy. Physiology 28, 225-233
39. Cornelius, D.C., Hogg, J.P., Scott, J., Wallace, K., Herse, F., Moseley, J., Wallukat, G., Dechend, R. and LaMarca, B. (2013) Administration of interleukin-17 soluble receptor C suppresses TH17 cells, oxidative stress, and hypertension in response to placental ischemia during pregnancy. Hypertension 62, 1068-1073
40. Irani, R.A., Zhang, Y., Zhou, C.C., Blackwell, S.C., Hicks, M.J., Ramin, S.M., Kellems, R.E. and Xia, Y. (2010) Autoantibody-mediated angiotensin receptor activation contributes to preeclampsia through tumor necrosis factor-alpha signaling. Hypertension 55, 1246-1253
41. Prins, J.R., Boelens, H.M., Heimweg, J., Van der Heide, S., Dubois, A.E., Van Oosterhout, A.J. and Erwich, J.J. (2009) Preeclampsia is associated with lower percentages of regulatory T cells in maternal blood. Hypertens. Pregnancy 28, 300-311
42. Santner-Nanan, B., Peek, M.J., Khanam, R., Richarts, L., Zhu, E., Fazekas de St Groth, B. and Nanan, R. (2009) Systemic increase in the ratio between Foxp3+ and IL-17-producing CD4+ T cells in healthy pregnancy but not in preeclampsia. J. Immunol. 183, 7023-7030
43. Wallace, K., Richards, S., Dhillon, P., Weimer, A., Edholm, E.S., Bengten, E., Wilson, M., Martin, Jr, J.N. and LaMarca, B. (2011) CD4+ T-helper cells stimulated in response to placental ischemia mediate hypertension during pregnancy. Hypertension 57, 949-955
44. Conrad, K.P. and Benyo, D.F. (1997) Placental cytokines and the pathogenesis of preeclampsia. Am. J. Reprod. Immunol. 37, 240-249
45. Dhillion, P., Wallace, K., Herse, F., Scott, J., Wallukat, G., Heath, J., Mosely, J., Martin, Jr, J.N., Dechend, R. and LaMarca, B. (2012) IL-17-mediated oxidative stress is an important stimulator of AT1-AA and hypertension during pregnancy. Am. J. Physiol. Regul. Integr. Comp. Physiol. 303, R353-R358
46. Granger, J.P., Alexander, B.T., Llinas, M.T., Bennett, W.A. and Khalil, R.A. (2002) Pathophysiology of preeclampsia: linking placental ischemia/hypoxia with microvascular dysfunction. Microcirculation 9, 147-160
47. LaMarca, B.B., Cockrell, K., Sullivan, E., Bennett, W. and Granger, J.P. (2005) Role of endothelin in mediating tumor necrosis factor-induced hypertension in pregnant rats. Hypertension 46, 82-86
48. LaMarca, B.D., Alexander, B.T., Gilbert, J.S., Ryan, M.J., Sedeek, M., Murphy, S.R. and Granger, J.P. (2008) Pathophysiology of hypertension in response to placental ischemia during pregnancy: a central role for endothelin? Gend. Med. 5 Suppl A, S133-S138
49. LaMarca, B., Wallace, K. and Granger, J. (2011) Role of angiotensin II type I receptor agonistic autoantibodies (AT1-AA) in preeclampsia. Curr. Opin. Pharmacol. 11, 175-179
50. Parrish, M.R., Ryan, M.J., Glover, P., Brewer, J., Ray, L., Dechend, R., Martin, Jr, J.N. and Lamarca, B.B. (2011) Angiotensin II type 1 autoantibody induced hypertension during pregnancy is associated with renal endothelial dysfunction. Gend. Med. 8, 184-188
51. Wenzel, K., Rajakumar, A., Haase, H., Geusens, N., Hubner, N., Schulz, H., Brewer, J., Roberts, L., Hubel, C.A., Herse, F. et al. (2011) Angiotensin II type 1 receptor antibodies and increased angiotensin II sensitivity in pregnant rats. Hypertension 58, 77-84
52. Zhou, C.C., Ahmad, S., Mi, T., Abbasi, S., Xia, L., Day, M.C., Ramin, S.M., Ahmed, A., Kellems, R.E. and Xia, Y. (2008) Autoantibody from women with preeclampsia induces soluble Fms-like tyrosine kinase-1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated T-cells signaling. Hypertension 51, 1010-1019
53. Bennett, W.A., Lagoo-Deenadayalan, S., Stopple, J.A., Barber, W.H., Hale, E., Brackin, M.N. and Cowan, B.D. (1998) Cytokine expression by first-trimester human chorionic villi. Am. J. Reprod. Immunol. 40, 309-318
54. Formby, B. (1995) Immunologic response in pregnancy. Its role in endocrine disorders of pregnancy and influence on the course of maternal autoimmune diseases. Endocrinol. Metab. Clin. North. Am. 24, 187-205
55. Hanna, N., Hanna, I., Hleb, M., Wagner, E., Dougherty, J., Balkundi, D., Padbury, J. and Sharma, S. (2000) Gestational age-dependent expression of IL-10 and its receptor in human placental tissues and isolated cytotrophoblasts. J. Immunol. 164, 5721-5728
56. Wegmann, T.G., Lin, H., Guilbert, L. and Mosmann, T.R. (1993) Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol. Today 14, 353-356
57. Lamarca, B. (2010) The role of immune activation in contributing to vascular dysfunction and the pathophysiology of hypertension during preeclampsia. Minerva Ginecol. 62, 105-120
58. Gadonski, G., LaMarca, B.B., Sullivan, E., Bennett, W., Chandler, D. and Granger, J.P. (2006) Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of interleukin 6. Hypertension 48, 711-716
59. Keiser, S.D., Veillon, E.W., Parrish, M.R., Bennett, W., Cockrell, K., Fournier, L., Granger, J.P., Martin, Jr, J.N. and Lamarca, B. (2009) Effects of 17-hydroxyprogesterone on tumor necrosis factor-alpha-induced hypertension during pregnancy. Am. J. Hypertens. 22, 1120-1125
60. Lamarca, B., Speed, J., Ray, L.F., Cockrell, K., Wallukat, G., Dechend, R. and Granger, J. (2011) Hypertension in response to IL-6 during pregnancy: role of AT1-receptor activation. Int. J. Infereron Cytokine Mediator Res. 201, 65-70
61. Zhou, C.C., Irani, R.A., Dai, Y., Blackwell, S.C., Hicks, M.J., Ramin, S.M., Kellems, R.E. and Xia, Y. (2011) Autoantibody-mediated IL-6-dependent endothelin-1 elevation underlies pathogenesis in a mouse model of preeclampsia. J. Immunol. 186, 6024-6034
62. Arriaga-Pizano, L., Jimenez-Zamudio, L., Vadillo-Ortega, F., Martinez-Flores, A., Herrerias-Canedo, T. and Hernandez-Guerrero, C. (2005) The predominant Th1 cytokine profile in maternal plasma of preeclamptic women is not reflected in the choriodecidual and fetal compartments. J. Soc. Gynecol. Investig. 12, 335-342
63. Hennessy, A., Pilmore, H.L., Simmons, L.A. and Painter, D.M. (1999) A deficiency of placental IL-10 in preeclampsia. J. Immunol. 163, 3491-3495
64. Dechend, R., Homuth, V., Wallukat, G., Muller, D.N., Krause, M., Dudenhausen, J., Haller, H. and Luft, F.C. (2006) Agonistic antibodies directed at the angiotensin II, AT1 receptor in preeclampsia. J. Soc. Gynecol. Investig. 13, 79-86
65. Kharfi, A., Giguere, Y., Sapin, V., Masse, J., Dastugue, B. and Forest, J.C. (2003) Trophoblastic remodeling in normal and preeclamptic pregnancies: implication of cytokines. Clin. Biochem. 36, 323-331
66. Yoshizumi, M., Perrella, M.A., Burnett, Jr., J.C. and Lee, M.E. (1993) Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ. Res. 73, 205-209
67. Dekker, G.A., Kraayenbrink, A.A., Zeeman, G.G. and van Kamp, G.J. (1991) Increased plasma levels of the novel vasoconstrictor peptide endothelin in severe pre-eclampsia. Eur. J. Obstet. Gynecol. Reprod. Biol. 40, 215-220
68. Wang, M.X., Brown, M.A., Buddle, M.L., Carlton, M.A., Cario, G.M. and Whitworth, J.A. (1994) Endothelin excretion in hypertensive pregnancy. Relationship to glomerular filtration rate, blood pressure, and sodium excretion. Am. J. Hypertens. 7 4 Pt 1, 308-313
69. Wilkins, Jr., F.C., Alberola, A., Mizelle, H.L., Opgenorth, T.J. and Granger, J.P. (1995) Systemic hemodynamics and renal function during long-term pathophysiological increases in circulating endothelin. Am. J. Physiol. 268 2 Pt 2, R375-R381
70. Alexander, B.T., Rinewalt, A.N., Cockrell, K.L., Massey, M.B., Bennett, W.A. and Granger, J.P. (2001) Endothelin type a receptor blockade attenuates the hypertension in response to chronic reductions in uterine perfusion pressure. Hypertension 37 2 Pt 2, 485-489
71. Yang, X., Guo, L., Li, H., Chen, X. and Tong, X. (2012) Analysis of the original causes of placental oxidative stress in normal pregnancy and pre-eclampsia: a hypothesis. J. Matern. Fetal. Neonatal. Med. 25, 884-888
72. Kalyanaraman, B. (2013) Teaching the basics of redox biology to medical and graduate students: oxidants, antioxidants and disease mechanisms. Redox. Biol. 1, 244-257
73. Lappas, M., Mitton, A. and Permezel, M. (2010) In response to oxidative stress, the expression of inflammatory cytokines and antioxidant enzymes are impaired in placenta, but not adipose tissue, of women with gestational diabetes. J. Endocrinol. 204, 75-84
74. Matsubara, K., Matsubara, Y., Hyodo, S., Katayama, T. and Ito, M. (2010) Role of nitric oxide and reactive oxygen species in the pathogenesis of preeclampsia. J. Obstet. Gynaecol Res. 36, 239-247
75. Myatt, L. and Cui, X. (2004) Oxidative stress in the placenta. Histochem. Cell Biol. 122, 369-382
76. Yiyenoglu, O.B., Ugur, M.G., Ozcan, H.C., Can, G., Ozturk, E., Balat, O. and Erel, Ö. (2014) Assessment of oxidative stress markers in recurrent pregnancy loss: a prospective study. Arch. Gynecol. Obstet. 289, 1337-1340
77. Anumba, D.O., Robson, S.C., Boys, R.J. and Ford, G.A. (1999) Nitric oxide activity in the peripheral vasculature during normotensive and preeclamptic pregnancy. Am. J. Physiol. 277 2 Pt 2, H848-H854
78. Baylis, C. and Bloch, J. (1996) Nitric oxide (NO) in renal physiology and pathophysiology. Nephrol. Dial. Transplant. 11, 1955-1957
79. Alexander, B.T., Miller, M.T., Kassab, S., Novak, J., Reckelhoff, J.F., Kruckeberg, W.C. and Granger, J.P. (1999) Differential expression of renal nitric oxide synthase isoforms during pregnancy in rats. Hypertension 33 1 Pt 2, 435-439
80. Baylis, C., Mitruka, B. and Deng, A. (1992) Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J. Clin. Invest. 90, 278-281
81. Hofmann, S.R., Ettinger, R., Zhou, Y.J., Gadina, M., Lipsky, P., Siegel, R., Candotti, F. and O'Shea, J.J. (2002) Cytokines and their role in lymphoid development, differentiation and homeostasis. Curr. Opin. Allergy Clin. Immunol. 2, 495-506
82. Chen, L.M., Liu, B., Zhao, H.B., Stone, P., Chen, Q. and Chamley, L. (2010) IL-6, TNFalpha and TGFbeta promote nonapoptotic trophoblast deportation and subsequently causes endothelial cell activation. Placenta 31, 75-80
83. Hung, T.H., Charnock-Jones, D.S., Skepper, J.N. and Burton, G.J. (2004) Secretion of tumor necrosis factor-alpha from human placental tissues induced by hypoxia-reoxygenation causes endothelial cell activation in vitro: a potential mediator of the inflammatory response in preeclampsia. Am. J.. Pathol. 164, 1049-1061
84. Lockwood, C.J., Yen, C.F., Basar, M., Kayisli, U.A., Martel, M., Buhimschi, I., Buhimschi, C., Huang, S.J., Krikun, G. and Schatz, F. (2008) Preeclampsia-related inflammatory cytokines regulate interleukin-6 expression in human decidual cells. Am. J. Pathol. 172, 1571-1579
85. LaMarca, B., Parrish, M.R. and Wallace, K. (2012) Agonistic autoantibodies to the angiotensin II type I receptor cause pathophysiologic characteristics of preeclampsia. Gend. Med. 9, 139-146
86. Xia, Y., Zhou, C.C., Ramin, S.M. and Kellems, R.E. (2007) Angiotensin receptors, autoimmunity, and preeclampsia. J. Immunol. 179, 3391-3395
87. Wallukat, G., Homuth, V., Fischer, T., Lindschau, C., Horstkamp, B., Jupner, A., Baur, E., Nissen, E., Vetter, K. and Neichel, D (1999) Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J. Clin. Invest. 103, 945-952
88. Li, C., Ansari, R., Yu, Z. and Shah, D. (2000) Definitive molecular evidence of renin-angiotensin system in human uterine decidual cells. Hypertension 36, 159-164
89. Shah, D.M. (2006) The role of RAS in the pathogenesis of preeclampsia. Curr. Hypertens. Rep. +8, 144-152
90. Merrill, D.C., Karoly, M., Chen, K., Ferrario, C.M. and Brosnihan, K.B. (2002) Angiotensin-(1-7) in normal and preeclamptic pregnancy. Endocrine 18, 239-245
91. AbdAlla, S., Lother, H., el Massiery, A. and Quitterer, U. (2001) Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness. Nat. Med. 7, 1003-1009
92. Quitterer, U., Lother, H. and Abdalla, S. (2004) AT1 receptor heterodimers and angiotensin II responsiveness in preeclampsia. Semin. Nephrol. 24, 115-119
93. Parrish, M.R., Murphy, S.R., Rutland, S., Wallace, K., Wenzel, K., Wallukat, G., Keiser, S., Ray, L.F., Dechend, R., Martin, J.N. et al. (2010) The effect of immune factors, tumor necrosis factor-alpha, and agonistic autoantibodies to the angiotensin II type I receptor on soluble fms-like tyrosine-1 and soluble endoglin production in response to hypertension during pregnancy. Am. J. Hypertens. 23, 911-916
94. Novotny, S., Wallace, K., Herse, F., Moseley, J., Darby, M., Heath, J., Gill, J., Wallukat, G., Martin, J.N., Dechend, R. and LaMarca, B. (2013) CD4+ T cells play a critical role in mediating hypertension in response to placental ischemia. J. Hypertens. 2, 2-6
95. Aluvihare, V.R., Kallikourdis, M. and Betz, A.G. (2004) Regulatory T cells mediate maternal tolerance to the fetus. Nat. Immunol. 5, 266-271
96. Saito, S., Shiozaki, A., Sasaki, Y., Nakashima, A., Shima, T. and Ito, M. (2007) Regulatory T cells and regulatory natural killer (NK) cells play important roles in feto-maternal tolerance. Semin. Immunopathol. 29, 115-122
97. Samstein, R.M., Josefowicz, S.Z., Arvey, A., Treuting, P.M. and Rudensky, A.Y. (2012) Extrathymic generation of regulatory T cells in placental mammals mitigates maternal-fetal conflict. Cell 150, 29-38
98. Toldi, G., Svec, P., Vasarhelyi, B., Meszaros, G., Rigo, J., Tulassay, T. and Treszl, A. (2013) Decreased number of FoxP3+ regulatory T cells in preeclampsia. Acta Obstet. Gynecol. Scand. 87, 1229-1233
99. Raghupathy, R. (2013) Cytokines as key players in the pathophysiology of preeclampsia. Med. Princ. Pract. 22 Suppl 1, 8-19
100. Haimovici, F., Hill, J.A. and Anderson, D.J. (1991) The effects of soluble products of activated lymphocytes and macrophages on blastocyst implantation events in vitro. Biol. Reprod. 44, 69-75
101. Saito, S., Sakai, M., Sasaki, Y., Tanebe, K., Tsuda, H. and Michimata, T. (1999) Quantitative analysis of peripheral blood Th0, Th1, Th2 and the Th1:Th2 cell ratio during normal human pregnancy and preeclampsia. Clin. Exp. Immunol. 117, 550-555
102. Saito, S., Tsukaguchi, N., Hasegawa, T., Michimata, T., Tsuda, H. and Narita, N. (1999) Distribution of Th1, Th2, and Th0 and the Th1/Th2 cell ratios in human peripheral and endometrial T cells. Am. J. Reprod. Immunol. 42, 240-245
103. Saito, S., Nakashima, A., Shima, T. and Ito, M. (2010) Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy. Am. J. Reprod. Immunol. 63, 601-610
104. Cornelius, D.C. and Lamarca, B. (2014) TH17- and IL-17-mediated autoantibodies and placental oxidative stress play a role in the pathophysiology of pre-eclampsia. Minerva Ginecol. 66, 243-249
105. Sakaguchi, S., Yamaguchi, T., Nomura, T. and Ono, M. (2008) Regulatory T cells and immune tolerance. Cell. 133, 775-787
106. Sasaki, Y., Sakai, M., Miyazaki, S., Higuma, S., Shiozaki, A. and Saito, S. (2004) Decidual and peripheral blood CD4+CD25+ regulatory T cells in early pregnancy subjects and spontaneous abortion cases. Mol. Hum. Reprod. 10, 347-353
107. Liu, X., Liu, Y., Ding, M. and Wang, X. (2011) Reduced expression of indoleamine 2,3-dioxygenase participates in pathogenesis of preeclampsia via regulatory T cells. Mol. Med. Rep. 4, 53-58
108. Santillan, M.K., Pelham, C.J., Ketsawatsomkron, P., Santillan, D.A., Davis, D.R., Devor, E.J., Gibson-Corley, K.N., Scroggins, S.M., Grobe, J.L., Yang, B. et al. (2015) Pregnant mice lacking indoleamine 2,3-dioxygenase exhibit preeclampsia phenotypes. Physiol. Rep. 3, 1-9
109. Zenclussen, A.C., Fest, S., Joachim, R., Klapp, B.F. and Arck, P.C. (2004) Introducing a mouse model for pre-eclampsia: adoptive transfer of activated Th1 cells leads to pre-eclampsia-like symptoms exclusively in pregnant mice. Eur. J. Immunol. 34, 377-387
110. Redman, C.W. (2011) Preeclampsia: a multi-stress disorder. Rev. Med. Interne 32 Suppl 1, S41-S44
111. Li, J., LaMarca, B. and Reckelhoff, J.F. (2012) A model of preeclampsia in rats: the reduced uterine perfusion pressure (RUPP) model. Am. J. Physiol. Heart Circ. Physiol. 303, H1-H8
112. Alexander, B.T., Cockrell, K.L., Massey, M.B., Bennett, W.A. and Granger, J.P. (2002) Tumor necrosis factor-alpha-induced hypertension in pregnant rats results in decreased renal neuronal nitric oxide synthase expression. Am. J. Hypertens. 15 2 Pt 1, 170-175
113. Brown, C.E., Gant, N.F., Cox, K., Spitz, B., Rosenfeld, C.R. and Magness, R.R. (1990) Low-dose aspirin. II. Relationship of angiotensin II pressor responses, circulating eicosanoids, and pregnancy outcome. Am. J. Obstet. Gynecol. 163 6 Pt 1, 1853-1861
114. Hladunewich, M., Karumanchi, S.A. and Lafayette, R. (2007) Pathophysiology of the clinical manifestations of preeclampsia. Clin. J. Am. Soc. Nephrol. 2, 543-549
115. Khalil, R.A. and Granger, J.P. (2002) Vascular mechanisms of increased arterial pressure in preeclampsia: lessons from animal models. Am. J. Physiol. Regul. Integr. Comp. Physiol. 283, R29-R45
116. Crews, J.K., Herrington, J.N., Granger, J.P. and Khalil, R.A. (2000) Decreased endothelium-dependent vascular relaxation during reduction of uterine perfusion pressure in pregnant rat. Hypertension 35 1 Pt 2, 367-372
117. Alexander, B.T., Kassab, S.E., Miller, M.T., Abram, S.R., Reckelhoff, J.F., Bennett, W.A. and Granger, J.P. (2001) Reduced uterine perfusion pressure during pregnancy in the rat is associated with increases in arterial pressure and changes in renal nitric oxide. Hypertension 37, 1191-1195
118. Murphy, J.G., Herrington, J.N., Granger, J.P. and Khalil, R.A. (2003) Enhanced [Ca2+]i in renal arterial smooth muscle cells of pregnant rats with reduced uterine perfusion pressure. Am. J. Physiol. Heart Circ. Physiol. 284, H393-H403
119. Roberts, L., LaMarca, B.B., Fournier, L., Bain, J., Cockrell, K. and Granger, J.P. (2006) Enhanced endothelin synthesis by endothelial cells exposed to sera from pregnant rats with decreased uterine perfusion. Hypertension 47, 615-618
120. Sedeek, M., Gilbert, J.S., LaMarca, B.B., Sholook, M., Chandler, D.L., Wang, Y. and Granger, J.P. (2008) Role of reactive oxygen species in hypertension produced by reduced uterine perfusion in pregnant rats. Am. J. Hypertens. 21, 1152-1156
121. Gilbert, J.S., Babcock, S.A. and Granger, J.P. (2007) Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble fms-like tyrosine kinase-1 expression. Hypertension 50, 1142-1147
122. Gilbert, J.S., Gilbert, S.A., Arany, M. and Granger, J.P. (2009) Hypertension produced by placental ischemia in pregnant rats is associated with increased soluble endoglin expression. Hypertension 53, 399-403
123. Novotny, S.R., Wallace, K., Heath, J., Moseley, J., Dhillon, P., Weimer, A., Wallukat, G., Herse, F., Wenzel, K., Martin, Jr, J.N. et al. (2012) Activating autoantibodies to the angiotensin II type I receptor play an important role in mediating hypertension in response to adoptive transfer of CD4+ T lymphocytes from placental ischemic rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 302, R1197-R1201
124. Kleinewietfeld, M. and Hafler, D.A. (2014) Regulatory T cells in autoimmune neuroinflammation. Immunol. Rev. 259, 231-244
125. Quinn, K.H., Lacoursiere, D.Y., Cui, L., Bui, J. and Parast, M.M. (2011) The unique pathophysiology of early-onset severe preeclampsia: role of decidual T regulatory cells. J. Reprod. Immunol. 91, 76-82
126. Ito, T., Hanabuchi, S., Wang, Y.H., Park, W.R., Arima, K., Bover, L., Qin, F.X., Gilliet, M. and Liu, Y.J. (2008) Two functional subsets of FOXP3+ regulatory T cells in human thymus and periphery. Immunity 28, 870-880
127. Sasaki, Y., Darmochwal-Kolarz, D., Suzuki, D., Sakai, M., Ito, M., Shima, T., Shiozaki, A., Rolinski, J. and Saito, S. (2007) Proportion of peripheral blood and decidual CD4(+) CD25(bright) regulatory T cells in pre-eclampsia. Clin. Exp. Immunol. 149, 139-145
128. Munoz-Suano, A., Hamilton, A.B. and Betz, A.G. (2011) Gimme shelter: the immune system during pregnancy. Immunol. Rev. 241, 20-38
129. von Rango, U. (2008) Fetal tolerance in human pregnancy-a crucial balance between acceptance and limitation of trophoblast invasion. Immunol. Lett. 115, 21-32
130. Jankovic, D., Kullberg, M.C., Feng, C.G., Goldszmid, R.S., Collazo, C.M., Wilson, M., Wynn, T.A., Kamanaka, M., Flavell, R.A. and Sher, A. (2007) Conventional T-bet(+)Foxp3(-) Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection. J. Exp. Med. 204, 273-283
131. Nevers, T., Kalkunte, S. and Sharma, S. (2011) Uterine regulatory T cells, IL-10 and hypertension. Am. J.Reprod.Immunol. 66 Suppl 1, 88-92
132. Shaw, M.H., Freeman, G.J., Scott, M.F., Fox, B.A., Bzik, D.J., Belkaid, Y. and Yap, G.S. (2006) Tyk2 negatively regulates adaptive Th1 immunity by mediating IL-10 signaling and promoting IFN-gamma-dependent IL-10 reactivation. J. Immunol. 176, 7263-7271
133. Heo, Y.J., Joo, Y.B., Oh, H.J., Park, M.K., Heo, Y.M., Cho, M.L., Kwok, S.K., Ju, J.H., Park, K.S., Cho, S.G. et al. (2010) IL-10 suppresses Th17 cells and promotes regulatory T cells in the CD4+ T cell population of rheumatoid arthritis patients. Immunol. Lett. 127, 150-156
134. Murai, M., Turovskaya, O., Kim, G., Madan, R., Karp, C.L., Cheroutre, H. and Kronenberg, M. (2009) Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis. Nat. Immunol. 10, 1178-1184
135. Jonuleit, H., Schmitt, E., Schuler, G., Knop, J. and Enk, A.H. (2000) Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 192, 1213-1222
136. Gu, Y., Yang, J., Ouyang, X., Liu, W., Li, H., Yang, J., Bromberg, J., Chen, S.H., Mayer, L., Unkeless, J.C. and Xiong, H. (2008) Interleukin 10 suppresses Th17 cytokines secreted by macrophages and T cells. Eur. J. Immunol. +38, 1807-1813
137. Lochner, M., Peduto, L., Cherrier, M., Sawa, S., Langa, F., Varona, R., Riethmacher, D., Si-Tahar, M., Di Santo, J.P. and Eberl, G. (2008) In vivo equilibrium of proinflammatory IL-17+ and regulatory IL-10+ Foxp3+ RORgamma t+ T cells. J. Exp. Med. 205, 1381-1393
138. Simpson, K.L., Keelan, J.A. and Mitchell, M.D. (1998) Labor-associated changes in interleukin-10 production and its regulation by immunomodulators in human choriodecidua. J. Clin. Endocrinol. Metab. 83, 4332-4337
139. Chaouat, G., Cayol, V., Mairovitz, V. and Dubanchet, S. (1999) Localization of the Th2 cytokines IL-3, IL-4, IL-10 at the fetomaternal interface during human and murine pregnancy and lack of requirement for Fas/Fas ligand interaction for a successful allogeneic pregnancy. Am. J. Reprod. Immunol. 42, 1-13
140. Bennett, W.A., Lagoo-Deenadayalan, S., Whitworth, N.S., Brackin, M.N., Hale, E. and Cowan, B.D. (1997) Expression and production of interleukin-10 by human trophoblast: relationship to pregnancy immunotolerance. Early Pregnancy 3, 190-198
141. Kalkunte, S., Lai, Z., Tewari, N., Chichester, C., Romero, R., Padbury, J. and Sharma, S. (2008) In vitro and in vivo evidence for lack of endovascular remodeling by third trimester trophoblasts. Placenta 29, 871-878
142. Lai, Z., Kalkunte, S. and Sharma, S. (2011) A critical role of interleukin-10 in modulating hypoxia-induced preeclampsia-like disease in mice. Hypertension 57, 505-514
143. Makris, A., Xu, B., Yu, B., Thornton, C. and Hennessy, A. (2006) Placental deficiency of interleukin-10 (IL-10) in preeclampsia and its relationship to an IL10 promoter polymorphism. Placenta 27, 445-451
144. Rein, D.T., Breidenbach, M., Honscheid, B., Friebe-Hoffmann, U., Engel, H., Gohring, U.J., Uekermann, L., Kurbacher, C.M. and Schöndorf, T. (2003) Preeclamptic women are deficient of interleukin-10 as assessed by cytokine release of trophoblast cells in vitro. Cytokine 23, 119-125
145. Tinsley, J.H., Chiasson, V.L., Mahajan, A., Young, K.J. and Mitchell, B.M. (2009) Toll-like receptor 3 activation during pregnancy elicits preeclampsia-like symptoms in rats. Am. J. Hypertens. 22, 1314-1319
146. Chatterjee, P., Chiasson, V.L., Kopriva, S.E., Young, K.J., Chatterjee, V., Jones, K.A. and Mitchell, B.M. (2011) Interleukin 10 deficiency exacerbates toll-like receptor 3-induced preeclampsia-like symptoms in mice. Hypertension 58, 489-496
147. Markert, U.R., Fitzgerald, J.S., Seyfarth, L., Heinzelmann, J., Varosi, F., Voigt, S., Schleussner, E. and Seewald, H.J. (2005) Lessons from reproductive immunology for other fields of immunology and clinical approaches. Chem. Immunol. Allergy 89, 169-179
148. Zemse, S.M., Hilgers, R.H., Simkins, G.B., Rudic, R.D. and Webb, R.C. (2008) Restoration of endothelin-1-induced impairment in endothelium-dependent relaxation by interleukin-10 in murine aortic rings. Can. J. Physiol. Pharmacol. 86, 557-565
149. Tinsley, J.H., South, S., Chiasson, V.L. and Mitchell, B.M. (2010) Interleukin-10 reduces inflammation, endothelial dysfunction, and blood pressure in hypertensive pregnant rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 298, R713-R719
150. Cornelius, D.C., Amaral, L.M., Harmon, A.C., Wallace, K., Thomas, A.J., Campbell, N., Scott, J., Herse, F., Haase, N., Moseley, J. et al. (2015) An increased population of regulatory T cells improves the pathophysiology of placental ischemia in a rat model of preeclampsia. Am. J. Physiol. Regul. Integr. Comp. Physiol. 309, R884-R891
151. Harmon, A., Cornelius, D., Amaral, L., Paige, A., Herse, F., Ibrahim, T., Wallukat, G., Faulkner, J., Moseley, J., Dechend, R. and LaMarca, B. (2015) IL-10 supplementation increases Tregs and decreases hypertension in the RUPP rat model of preeclampsia. Hypertens. Pregnancy 34, 291-306
152. Darby, M.M., Wallace, K., Cornelius, D., Chatman, K.T., Mosely, J.N., Martin, J.N., Purser, C.A., Baker, R.C., Owens, M.T. and Lamarca, B.B. (2013) Vitamin D supplementation suppresses hypoxia-stimulated placental cytokine secretion, hypertension and CD4 T cell stimulation in response to placental ischemia. Med. J. Obstet. Gynecol. 1, 1012
153. LaMarca, B., Wallace, K., Herse, F., Wallukat, G., Martin, Jr., J.N., Weimer, A. and Dechend, R. (2011) Hypertension in response to placental ischemia during pregnancy: role of B lymphocytes. Hypertension 57, 865-871